amikacin has been researched along with Central Nervous System Infection in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, J; Liu, Y; Wang, H; Wu, G; Xu, X | 1 |
| Chen, Y; Feng, H; Hu, H; Jiang, Y; Qu, T; Shen, P; Wang, H; Yang, Q; Yu, M; Zhang, S; Zhang, Y | 1 |
| Alexandropoulos, P; Chantziara, V; Chinou, E; Georgiou, S; Lagiou, F; Micha, G; Michaloudis, G; Tsimogianni, A; Vassi, A | 1 |
| Midani, S; Rathore, MH | 1 |
1 review(s) available for amikacin and Central Nervous System Infection
| Article | Year |
|---|---|
Mycobacterium fortuitum infection of ventriculoperitoneal shunt.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Causality; Central Nervous System Infections; Cross Infection; Debridement; Drainage; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Male; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Trimethoprim, Sulfamethoxazole Drug Combination; Ventriculoperitoneal Shunt | 1999 |
3 other study(ies) available for amikacin and Central Nervous System Infection
| Article | Year |
|---|---|
Intravenous plus intraventricular tigecycline-amikacin therapy for the treatment of carbapenem-resistant Klebsiella pneumoniae ventriculitis: A case report.
Topics: Amikacin; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Central Nervous System Infections; Cerebral Ventriculitis; Encephalitis; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Tigecycline | 2022 |
Clinical and microbiological characteristics of carbapenem-resistant Enterobacteriaceae causing post-operative central nervous system infections in China.
Topics: Amikacin; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Central Nervous System Infections; Enterobacteriaceae Infections; Humans; Multilocus Sequence Typing | 2023 |
Intrathecal or intraventricular administration of colistin, vancomycin and amikacin for central nervous system infections in neurosurgical patients in an intensive care unit.
Topics: Amikacin; Anti-Bacterial Agents; C-Reactive Protein; Central Nervous System Infections; Colistin; Humans; Injections, Intraventricular; Injections, Spinal; Intensive Care Units; Neurosurgical Procedures; Retrospective Studies; Vancomycin | 2017 |